PTGS2 and lung cancer: Thus, miR-199a-3p was chosen for this study because it uniquely intersects both inflammatory regulation of COX-2 and antitumor activity in lung cancer cells, positioning it as a compelling candidate to mediate thymoquinone’s effects on COX-2/PGE2 and oncogenic signaling pathways.